Two‐year outcomes for the Altis<sup>®</sup> adjustable single incision sling system for treatment of stress urinary incontinence

Kocjancic, Ervin; Erickson, Ty; Tu, Le Mai; Gheiler, Edward L.; Drie, Douglas Van

doi:10.1002/nau.23156

Cited by 20 publications

(34 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These are also the cases with higher failure rates. We do not think that hypermobility or ISD should be managed as dichotomous problems but rather as a continuous condition because frequently these two entities coexist . In fact, 91% of our present patients had urethral hypermobility in the physical examination with a positive Marshall–Bonney test.…”

Section: Discussionmentioning

confidence: 62%

See 1 more Smart Citation

Mid‐term safety and efficacy of the ALTIS^® single‐incision sling for female stress urinary incontinence: less mesh, same results

et al. 2018

View full text Add to dashboard Cite

Objective To analyse the mid‐term safety and efficacy of the ALTIS® single‐incision sling (Coloplast Corp., Minneapolis, MN, USA) for female stress urinary incontinence (SUI). Patients and Methods We conducted a prospective, single‐arm, unsponsored, observational single‐centre trial in a cohort of patients undergoing SUI surgery with the ALTIS procedure. All patients were diagnosed according to clinical reports, physical exploration and urodynamics. Body mass index (BMI) was categorised according to World Health Organization classification. Valsalva leak‐point pressure (VLPP) was categorised in three groups: <60, 60–90 and >90 cmH2O. Patients were evaluated postoperatively at 1, 6, 12 and 24 months with physical examination, International Consultation on Incontinence Questionnaire Short Form (ICIQ‐SF), and satisfaction visual scale (SVS; score 0–10). Adverse events were assessed at each visit. Multivariate analysis for risk factors of surgery failure was performed. Results We recruited 110 women, with a mean (SD) follow‐up of 22.34 (10.34) months. Regarding efficacy, 91 patients (82.7%) were objectively cured and 97 (88.2%) were subjectively cured. Regarding VLPP and BMI, no differences were seen between groups (P > 0.05). There was a ~20% decrease in urge UI (P = 0.04). No variable showed to be an independent risk factor for ALTIS failure (P > 0.05). Overall, nearly 96% of the women reported 9 or 10 points on the SVS. A total of 24 patients (21.8%) had some kind of complication. No mesh erosion was reported in any patient. Conclusions The ALTIS sling demonstrated to be an effective and safe procedure for SUI in the mid‐term setting. Objective and subjective cure rates are at least comparable to ‘gold standard’ procedures with a minimal rate of self‐limiting non‐surgical complications.

show abstract

Section: Discussionmentioning

confidence: 62%

“…Kocjancic et al described an objective cure rate, evaluated with the cough stress test, of 88%. In that study, 90% of patients reported to be ‘very much better’ or ‘much better’, which we could assume to be equivalent to 9 or 10 points on the SVS.…”

Section: Discussionmentioning

confidence: 99%

Mid‐term safety and efficacy of the ALTIS^® single‐incision sling for female stress urinary incontinence: less mesh, same results

et al. 2018

View full text Add to dashboard Cite

show abstract

“…Most of the scientific publications are retrospective observational studies, 13,15 and prospective single-center 16,17 or multicenter. 18 Our work is a prospective observational single-center study with a 6-year follow-up. The literature reviewed reports follow-ups at 1year, 13,16,19,20 2years 17,18 and 3years.…”

Section: Discussionmentioning

confidence: 99%

Six-year follow-up in patients with urinary stress incontinence treated with Altis® single-incision sling: a prospective single-center study

Viruega-Cuaresma¹,

De-Miguel-Manso²,

García-García³

et al. 2021

OGIJ

View full text Add to dashboard Cite

Objetives: Single incision slings are the latest generation of suburethral bands that seek to minimize morbidity and major complications of transobturator bands. In short and medium term, their results in terms of success and safety are similar to transobturator and retropubic bands. Nevertheless, there is little data on their long-term outcomes. Our objective was to evaluate safety and efficacy of Altis® mini-sling during the short, medium and long-term follow-up. Methods: Prospective observational study in 67 women who underwent surgery with Altis® for a period of 6 years (2013-2019). The main variables evaluated were: total continence, objective cure and subjective cure (satisfaction). The secondary variables studied were: complications and number of pads used per day after surgery. Statistics: Student t-test or U-Mann-Whitney for quantitative variables, Chi-Square for categorical variables. Results: Objective cure rates were: 96.77%, 87.04%, 87.50%, 85.71%, 76.92% and 50% (from 1 to 6years), and total continence: 85.48%, 72.22%, 64.88%, 50%, 46.15% and 50% (from 1 to 6years). Degree of satisfaction was: 9, 8.2, 8.3, 7.7, 7.6 and 6.5 points (from 1 to 6years). 30 patients (44.78%) had some type of complication and the most common were: “de novo” urinary urgency (20.90%), recurrence of stress urinary incontinence (14.93%) and pain (5.97%). Conclusion: Altis® presents high rates of objective and subjective continence in short and medium-term (1-5years), during 6-year follow-up. It is safe and does not associate severe complications. We found a high percentage of “de novo” urgency and recurrence of stress urinary incontinence, especially after the fifth year.

show abstract

“…The SIMS presented was an adjustable polypropylene mesh, fixated in the obturator membrane with anchors, and introduced with a helicopasser (Altis® Single Incision Sling System; Coloplast®; The Netherlands). Single‐arm cohort studies show subjective and objective cure rates of 84% and 90%, respectively at 12‐month follow‐up, with durable results at 24‐month follow‐up …”

Section: Methodsmentioning

confidence: 99%

“…Single-arm cohort studies show subjective and objective cure rates of 84% and 90%, respectively at 12-month follow-up, with durable results at 24-month follow-up. 14,15…”

Section: Trade-off Experimentsmentioning

confidence: 99%

How cure rates drive patients' preference for urethral bulking agent or mid‐urethral sling surgery as therapy for stress urinary incontinence

Casteleijn

Enklaar

Bouyahyaoui

et al. 2019

Neurourology and Urodynamics

View full text Add to dashboard Cite

Aims To assess the patients' median‐accepted threshold of cure rate for urethral bulking agent (UBA) treatment compared to mid‐urethral sling (MUS) surgery for treatment of female stress urinary incontinence (SUI). Secondly, to determine the correlation between treatment trade‐off point and patient characteristics. Methods Women older than 18 years, with predominant SUI, seeking treatment, underwent a structured interview. The treatment trade‐off point was determined in scenario one: UBA vs transobturator standard MUS surgery (SMUS) performed under general/spinal anesthesia with one‐night hospital stay, and scenario 2: UBA compared to single‐incision MUS surgery (SIMS) performed under local analgesia (with sedation) in a daycare setting. The treatment trade‐off point was assessed by decreasing the cure rate of UBA from 85% to 10% with steps of 2% until the patient's treatment preference switched to SMUS/SIMS. Results One hundred and five patients were interviewed. Mean age was 52 years (SD, ±13.4). The median trade‐off point for scenarios 1 and 2 was 79% (interquartile range [IQR]: 69, 85) and 85% (IQR: 71, 85), respectively. Patients with longer duration of SUI symptoms were willing to trade more efficacy to prefer UBA treatment. Conclusions Patients with SUI are willing to trade a lower cure rate to prefer UBA over SMUS to avoid hospitalization and general anesthesia. When SIMS is performed in a daycare setting under local analgesia, the majority of patients with SUI are of the opinion that cure rates of UBA should be at least as high as SIMS to be worth considering. The treatment preference is not strongly correlated with the patients' characteristics.

show abstract

Two‐year outcomes for the Altis^® adjustable single incision sling system for treatment of stress urinary incontinence

Abstract: The Altis single-incision sling is a durable and effective treatment with a favorable safety profile for surgical treatment of women with stress or stress-predominant mixed urinary incontinence.

Cited by 20 publications

References 11 publications

Mid‐term safety and efficacy of the ALTIS^® single‐incision sling for female stress urinary incontinence: less mesh, same results

Mid‐term safety and efficacy of the ALTIS^® single‐incision sling for female stress urinary incontinence: less mesh, same results

Six-year follow-up in patients with urinary stress incontinence treated with Altis® single-incision sling: a prospective single-center study

How cure rates drive patients' preference for urethral bulking agent or mid‐urethral sling surgery as therapy for stress urinary incontinence

Contact Info

Product

Resources

About

Two‐year outcomes for the Altis® adjustable single incision sling system for treatment of stress urinary incontinence

Abstract: The Altis single-incision sling is a durable and effective treatment with a favorable safety profile for surgical treatment of women with stress or stress-predominant mixed urinary incontinence.

Cited by 20 publications

References 11 publications

Mid‐term safety and efficacy of the ALTIS® single‐incision sling for female stress urinary incontinence: less mesh, same results

Mid‐term safety and efficacy of the ALTIS® single‐incision sling for female stress urinary incontinence: less mesh, same results

Six-year follow-up in patients with urinary stress incontinence treated with Altis® single-incision sling: a prospective single-center study

How cure rates drive patients' preference for urethral bulking agent or mid‐urethral sling surgery as therapy for stress urinary incontinence

Contact Info

Product

Resources

About

Two‐year outcomes for the Altis^® adjustable single incision sling system for treatment of stress urinary incontinence

Mid‐term safety and efficacy of the ALTIS^® single‐incision sling for female stress urinary incontinence: less mesh, same results

Mid‐term safety and efficacy of the ALTIS^® single‐incision sling for female stress urinary incontinence: less mesh, same results